Kast, Richard E.

Lithium and hematology: established and proposed uses

Focosi, D., Azzarà, A., Kast, R. E., Carulli, G., & Petrini, M. (2009) · Journal of Leukocyte Biology

Blood disorders and treatmentsHematopoietic Stem Cell Transplantation

Cited by 98

A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3

Halatsch, M.-E., Kast, R. E., Karpel-Massler, G., Mayer, B., Zolk, O., Schmitz, B., Scheuerle, A., Maier, L., Bullinger, L., Mayer-Steinacker, R., et al. (2021) · Neuro-Oncology Advances

Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy

Cited by 74

Anti- and pro-inflammatory considerations in antidepressant use during medical illness: bupropion lowers and mirtazapine increases circulating tumor necrosis factor-alpha levels

Kast, R. E. (2003) · General Hospital Psychiatry

Cancer, Stress, Anesthesia, and Immune ResponseTryptophan and brain disorders

Cited by 62

Borage oil reduction of rheumatoid arthritis activity may be mediated by increased cAMP that suppresses tumor necrosis factor-alpha

Kast, R. E. (2001) · International Immunopharmacology

Rheumatoid Arthritis Research and TherapiesFatty Acid Research and Health

Cited by 60

Remission of Crohn's disease on bupropion

Kast, R. E., & Altschuler, E. L. (2001) · Gastroenterology

Inflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies

Cited by 58

Crohn's disease remission with phenelzine treatment

Kast, R. E. (1998) · Gastroenterology

Inflammatory Bowel DiseasePregnancy and Medication Impact

Cited by 43

In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma

Halatsch, M.-E., Dwucet, A., Schmidt, C. J., Mühlnickel, J., Heiland, T., Zeiler, K., Siegelin, M. D., Kast, R. E., & Karpel-Massler, G. (2021) · Pharmaceuticals

Glioma Diagnosis and TreatmentNeuroprotection in Cerebral Ischemia

Cited by 26

IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone

Kast, R. E. (2024) · Oncoscience

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 6

Potential Benefits of Adding Alendronate, Celecoxib, Itraconazole, Ramelteon, and Simvastatin to Endometrial Cancer Treatment: The EC5 Regimen

Kast, R. E. (2025) · Current Issues in Molecular Biology

Endometrial and Cervical Cancer TreatmentsCancer, Lipids, and Metabolism

Cited by 5

IC Regimen: Delaying Resistance to Lorlatinib in ALK Driven Cancers by Adding Repurposed Itraconazole and Cilostazol

Kast, R. E. (2024) · Cells

Lung Cancer Treatments and MutationsLung Cancer Research Studies

Cited by 4